Seneste opdatering :
19/11/2024
Analgetisk   Morphine tartrate  
Injektion
Stabilitet i (vandige) opløsninger Stabilitet i blandinger Faktorer der påvirker stabiliteten Kompatibilitet Administrationsvej Bibliografi pdf
   Kemisk struktur  

Handelsnavn   Handelsnavn     

Handel navne er vejledende og hjælpestoffer sammensætning kan være forskellig afhængigt af landet og laboratorier

Morphine tartrate Australien
Bibliografi   Injektion   Bibliografi : Morphine tartrate  
Type offentliggørelse
519 Journal Poggi GL.
Compatibility of morphine tartrate admixtures in polypropylene syringes.
Aust J Hosp Pharm 1991 ; 21: 316.
920 Journal Targett PL, Keefe PA, Merridew CG.
Stability of two concentrations of morphine tartrate in 10 mL polypropylene syringes.
Aust J Hosp Pharm 1997 ; 27: 452-454.
980 Journal Ambados F.
Compatibility of morphine and ketamine for subcutaneous infusion.
Aust J Hosp Pharm 1995 ; 25: 352.
1864 Journal Lau MH, Hackman C, Morgan DJ.
Compatibility of ketamine and morphin injections.
Pain 1998 ; 75: 389-390.
2083 Journal La Forgia SP, Sharley NA, Burgess NG, Doecke CJ.
Stability and compatibility of morphine, midazolam and bupivacaine combinaisons for iontravenous infusion.
J Pharm Pract and Res 2002 ; 32: 65-68.
3474 Laboratorium Fluorouracil - Summary of Product Characteristics
Accord Healthcare Limited 2009
3504 Laboratorium Parecoxib (Dynastat®) - Summary of Product Characteristics
Pfizer 2012
3644 Laboratorium Calcium gluconate® - Summary of Product Characteristics
Hameln Pharmaceuticals 2010
3675 Laboratorium Thiopental sodium - Summary of Product Characteristics
Archimedes Pharma UK Ltd 2015
3838 Laboratorium Magnesium Sulphate - Summary of Product Characteristics
Martindale Pharmaceuticals Ltd 2007
3934 Laboratorium Eptifibatide (Integrilin®) - Résumé des caractéristiques du produit
GlaxoSmithKline Laboratoire 2016

  Mentions Légales